Member Info for ratcliffewriter

Dangerous people those Methodists.

That explains the tinfoil hat...

Given the aggressively entrpeneurial nature of Chinese business, I wonder if Scancell presenting in China might at the very least concentrate a few minds in the USA or Europe.

A 425,000 buy at 10.25p at 3.52pm yesterday. Another hefty buy methinks. The 'Grim Hold' is getting a little less grim this week.

One can only assume their line of sells has now dried up.

and thanks inan for the excellent contributions these days!

Inanaco - I haven't listened to the recording yet, but just dipped in to the point you refer to. Is that the bit where Lindy (not known for anything other than very matter-of-fact presentation of facts) says '...and we can get absolutely every cancer cell'? I did a bit of a double take at the very calm way such a fact was reported, and having met her and followed her over the years I trust her judgement completely. I have rated this entry as 'strong buy' simply because there is no stronger recommendation!

IMO an over-reaction to an RNS followed by an AGM which laid many fears to rest and has allowed people to re-examine the positives.

Just had a look back at the SCIB1 RNSs - from one released on 2nd May 2012 it says - 'Patients will be treated with a 4mg dose of SCIB1 on five occasions over a period of 6 months. The study is expected to take 18 months to complete.'
It was during the 6 months of doseage that things really started to transform - the patients responded better than expected, the dosage was allowed to be increased, the trial was given most unusual permission to extend to 5 years, no side effects appeared, and as you know, the patients did so well that at least one of them recovered, went back to work, got married and the last I heard had resumed normal life. Lets face it, most or all of the patients were expected to be dead after 6 months, so the extended trial was due not to 'delay' but to exceptional results and success. Nobody expected the work to be as successful as it was, or if they did, they kept their expectations under wraps to retain credible scientific level-headedness. And that's why the news releases sometimes sound low-key, when in actual fact they are stunning - but if you start letting off party poppers and decking the lab with balloons it can look as if you are making too much of something. I think party time will come along just fine in a bit, possibly sooner than some expect.

DA please read the previous posts more carefully. It is NOT a TW comment. It is from Nigel Somerville who is very different in 3 key areas from TW - a) he owns shares b) he has no ulterior motive in his comments and c) he knows what he is talking about here.

Very true crumbs - point missed by some and nastily twisted by others. If I remember right (and feel free to correct if I have this wrong) but I seem to recall the SCIB1 trial was only expected to run for 6 months in the first instance, but was then so unexpectedly and immediately successful that it was extended for five years - and still working superbly then. Hence the comment 'well beyond established norms' from one of the top names in the world on immunotherapy.

It's not thirsty boy Winnifrith who wrote it - it's Nigel Somerville. TW just stuck an editorial jibe in, but has even less fundamental understanding of bios than he does of other shares. Somerville has given a fair summary of things imo. 'Grim Hold' is an excellent term!

Thanks for that RH - love the way TW has to have a dig, but doesn't mention some of his tips which have been catastrophic but he carefully ignores. (Minoan for one - pushing it as the best thing since sliced bread in the 10p area, and now languishing at 3. It's enough to drive you to drink...)

So the 1 million buy at 8.17 was balanced by the two 500k sells at 8p a few minutes later. As long as there is a line of stock to balance the increased buying then the price will presumably stay much the same as it has the last few days, but once that line dries up we should see a rise - which will obviously be welcome!

You know how it is, a bit of small change in your pocket, the dilemma of do I give it to charity or treat myself to something? So what the hell, just a small top up towards the end of the week....

Uncanny you posted 'the current late stage of 401 in Phase III trials'. 401 isn't in a P3 trial.

I'm talking about the revised date, not the original date - like shipping insurers drawing a line above the titanic and moving on from there.... You know what I mean - the current fixed and immutable date for GC results! They can't move it much more if it's to remain an annual event.

If you believe in the company then I have to say this is a very good top-up price IMO. Time will tell, but the GC results date is not going to slip and should be a good bit of publicity assuming Sclp win, of course!

With most shares it gnats' todgers on the way up, and giraffe necks on the way down.

A tick up. Makes a change to recent times! OK it's only a small one, but size isn't important. It really isn't. Honest luv.